Stocchi F - Search Results

1

Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study.

Babiloni C, Del Percio C, Lizio R, Noce G, Cordone S, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Nobili F, Arnaldi D, Aarsland D, Orzi F, Buttinelli C, Giubilei F, Onofrj M, Stocchi F, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Caravias G, Garn H, Sorpresi F, Pievani M, Frisoni GB, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Başar E, Yener G, Emek-Savaş DD, Triggiani AI, Franciotti R, De Pandis MF, Bonanni L. Babiloni C, et al. Among authors: stocchi f. Neurobiol Aging. 2017 Jul;55:143-158. doi: 10.1016/j.neurobiolaging.2017.03.030. Epub 2017 Apr 5. Neurobiol Aging. 2017. PMID: 28454845

2

Urinary and anorectal function evaluation in Parkinson's disease.

Stocchi F, Corazziari E, Carbone A, Vacca L, De Pandis MF, Berardelli A, Ruggieri SA. Stocchi F, et al. Adv Neurol. 1999;80:347-51. Adv Neurol. 1999. PMID: 10410740 No abstract available.

3

Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results.

Stocchi F, Vacca L, De Pandis MF, Barbato L, Valente M, Ruggieri S. Stocchi F, et al. Neurol Sci. 2001 Feb;22(1):93-4. doi: 10.1007/s100720170062. Neurol Sci. 2001. PMID: 11487217 Clinical Trial.

4

Are there clinically significant differences between dopamine agonists.

Stocchi F, Vacca L, Onofrj M. Stocchi F, et al. Adv Neurol. 2003;91:259-66. Adv Neurol. 2003. PMID: 12442684 Review. No abstract available.

5

Combination of two different dopamine agonists in the management of Parkinson's disease.

Stocchi F, Berardelli A, Vacca L, Thomas A, De Pandis MF, Modugno N, Valente M, Ruggieri S. Stocchi F, et al. Neurol Sci. 2002 Sep;23 Suppl 2:S115-6. doi: 10.1007/s100720200096. Neurol Sci. 2002. PMID: 12548370 Clinical Trial.

6

Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.

Stocchi F, Vacca L, Grassini P, De Pandis MF, Battaglia G, Cattaneo C, Fariello RG. Stocchi F, et al. Neurology. 2006 Oct 10;67(7 Suppl 2):S24-9. doi: 10.1212/wnl.67.7_suppl_2.s24. Neurology. 2006. PMID: 17030737 Clinical Trial.

7

End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease.

Thomas A, Bonanni L, Di Iorio A, Varanese S, Anzellotti F, D'Andreagiovanni A, Stocchi F, Onofrj M. Thomas A, et al. Among authors: stocchi f. J Neurol. 2006 Dec;253(12):1633-9. doi: 10.1007/s00415-006-0320-z. J Neurol. 2006. PMID: 17219034 Clinical Trial.

8

Utility of tolcapone in fluctuating Parkinson's disease.

Stocchi F, De Pandis MF. Stocchi F, et al. Clin Interv Aging. 2006;1(4):317-25. doi: 10.2147/ciia.2006.1.4.317. Clin Interv Aging. 2006. PMID: 18046910 Free PMC article. Review.

9

Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.

Onofrj M, Bonanni L, Cossu G, Manca D, Stocchi F, Thomas A. Onofrj M, et al. Among authors: stocchi f. Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S233-6. doi: 10.1016/S1353-8020(09)70821-1. Parkinsonism Relat Disord. 2009. PMID: 20082998 Review.

10

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients.

Stocchi F, Borgohain R, Onofrj M, Schapira AH, Bhatt M, Lucini V, Giuliani R, Anand R; Study 015 Investigators. Stocchi F, et al. Mov Disord. 2012 Jan;27(1):106-12. doi: 10.1002/mds.23954. Epub 2011 Sep 12. Mov Disord. 2012. PMID: 21913224 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

381 results

Search Page